| Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening (NCT01484665) | University of Minnesota | 2011-12-01 |
| Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer (NCT01501630) | Assistance Publique - Hôpitaux de Paris | 2011-12-01 |
| Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients (NCT01793077) | Astellas Pharma Europe B.V. | 2011-12-01 |
| 11C Acetate Imaging Post Prostatectomy (NCT01602783) | Massachusetts General Hospital | 2011-12-01 |
| EMBRACE1: Prostate Biorepository (NCT01499381) | Caris Science, Inc. | 2011-12-01 |
| Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer (NCT02302105) | Tata Memorial Centre | 2011-11-25 |
| Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA (NCT01521949) | University of Colorado, Denver | 2011-11-04 |
| Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort (NCT01565512) | Columbia University | 2011-11-01 |
| Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate Biopsy (NCT02220517) | Heinrich-Heine University, Duesseldorf | 2011-11-01 |
| The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery (NCT02773251) | Bucheon St. Mary's Hospital | 2011-11-01 |
| Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer (NCT01374087) | Ipsen | 2011-11-01 |
| The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function (NCT01547416) | Yonsei University | 2011-11-01 |
| Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy (NCT02460861) | University of Magdeburg | 2011-11-01 |
| Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer (NCT01481441) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2011-11-01 |
| Active Surveillance Magnetic Resonance Imaging Study (NCT01354171) | Canadian Urology Research Consortium | 2011-11-01 |
| Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy (NCT01516866) | University of Wisconsin, Madison | 2011-11-01 |
| Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer (NCT01483586) | KangLaiTe USA | 2011-11-01 |
| Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial (NCT01411332) | University of Miami | 2011-10-31 |
| Tecemotide (L-BLP25) in Prostate Cancer (NCT01496131) | EMD Serono | 2011-10-24 |
| A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant (NCT01437085) | AHS Cancer Control Alberta | 2011-10-01 |
| Methylselenocysteine Effects on Circadian Rhythm (NCT01611038) | Rutgers, The State University of New Jersey | 2011-10-01 |
| Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients (NCT01434342) | Wake Forest University Health Sciences | 2011-10-01 |
| Immune Profiles and Circulating Tumor Cell Status Following Prostate Cryotherapy (NCT01454037) | National Taiwan University Hospital | 2011-10-01 |
| Male Stress Urinary Incontinence and Sexual Health (NCT01379378) | Stanford University | 2011-10-01 |
| Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy (NCT02726113) | Medical University of South Carolina | 2011-10-01 |
| Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix. (NCT01448798) | Johann Wolfgang Goethe University Hospital | 2011-10-01 |
| A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01424930) | Janssen-Ortho Inc., Canada | 2011-10-01 |
| Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery (NCT01495130) | University of Southern California | 2011-10-01 |
| Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia (NCT01444456) | Amgen | 2011-10-01 |
| Saw Palmetto: Symptom Management for Men During Radiation Therapy (NCT01585246) | Michigan State University | 2011-10-01 |
| Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer (NCT01420250) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-09-22 |
| A Novel 3D Navigation Technology for Improved TRUS Prostate Biopsy (NCT01480375) | UC Care, Ltd. | 2011-09-22 |
| A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer (NCT01331083) | NCIC Clinical Trials Group | 2011-09-09 |
| Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer (NCT01497925) | Polaris Group | 2011-09-06 |
| Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery (NCT01660152) | Ohio State University Comprehensive Cancer Center | 2011-09-01 |
| Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies (NCT01594502) | University of Illinois at Chicago | 2011-09-01 |
| Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer (NCT01436968) | Candel Therapeutics, Inc. | 2011-09-01 |
| Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer (NCT01368055) | University of Florida | 2011-09-01 |
| Transrectal Photoacoustic Imaging of the Prostate (NCT02365883) | Stanford University | 2011-09-01 |
| A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT01400555) | Cougar Biotechnology, Inc. | 2011-09-01 |
| Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer (NCT01505075) | Sunnybrook Health Sciences Centre | 2011-09-01 |
| Radiation Therapy in Treating Patients With Prostate Cancer (NCT01434290) | Radiation Therapy Oncology Group | 2011-09-01 |
| GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer (NCT01420861) | GTx | 2011-09-01 |
| HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy (NCT01409876) | University Hospital Erlangen | 2011-09-01 |
| FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer (NCT01439542) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2011-09-01 |
| Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer (NCT01393730) | Mary-Ellen Taplin, MD | 2011-09-01 |
| Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer (NCT01415960) | GP-Pharm | 2011-09-01 |
| Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies. (NCT01455792) | Oslo University Hospital | 2011-09-01 |
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer (NCT01431391) | Dendreon | 2011-09-01 |
| A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer (NCT01685983) | Janssen Research & Development, LLC | 2011-08-30 |
| MR Image Guided Therapy in Prostate Cancer (NCT01377753) | National Cancer Institute (NCI) | 2011-08-12 |
| S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy (NCT01309672) | SWOG Cancer Research Network | 2011-08-09 |
| An Open Label Prostate Cancer Study in Japanese Patients (NCT01351688) | AstraZeneca | 2011-08-01 |
| Phase II, Dose Finding Study of GTx-758 (NCT01393119) | GTx | 2011-08-01 |
| Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery (NCT01794936) | Columbia University | 2011-08-01 |
| BKM120 in Metastatic Castration-resistant Prostate Cancer (NCT01385293) | Andrew J. Armstrong, MD | 2011-08-01 |
| Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer (NCT01409473) | Rocky Mountain Cancer Centers | 2011-08-01 |
| Pilot Study on Focal Prostate Radio-Frequency Ablation (NCT01423006) | H. Lee Moffitt Cancer Center and Research Institute | 2011-08-01 |
| Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer (NCT01436214) | Adamis Pharmaceuticals Corporation | 2011-08-01 |
| Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences (NCT01355185) | AHS Cancer Control Alberta | 2011-08-01 |
| Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy (NCT01555086) | Association of Urologic Oncology (AUO) | 2011-08-01 |
| Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer (NCT01428869) | University Health Network, Toronto | 2011-08-01 |
| Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer (NCT01398657) | National Taiwan University Hospital | 2011-07-01 |
| Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients (NCT01705652) | The University of Texas Health Science Center at San Antonio | 2011-07-01 |
| Online Study of Colorectal Cancer and Prostate Cancer Screening Decision Making (NCT01558583) | University of North Carolina, Chapel Hill | 2011-07-01 |
| Safety Study of MGA271 in Refractory Cancer (NCT01391143) | MacroGenics | 2011-07-01 |
| Circulating Tumor Cells in Prostate Cancer Patients (NCT01414712) | University of Texas Southwestern Medical Center | 2011-07-01 |
| Degarelix Before Radical Prostatectomy (NCT01852864) | University of Cambridge | 2011-07-01 |
| Trial of Modifications to Radical Prostatectomy (NCT01407263) | Memorial Sloan Kettering Cancer Center | 2011-07-01 |
| Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer (NCT01317199) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-07-01 |
| Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer (NCT01368588) | Radiation Therapy Oncology Group | 2011-07-01 |
| Focal Therapy for Prostate Cancer Using HIFU (NCT01194648) | University College, London | 2011-06-29 |
| Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study (NCT01386684) | AbbVie (prior sponsor, Abbott) | 2011-06-28 |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer (NCT01377389) | M.D. Anderson Cancer Center | 2011-06-17 |
| Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer (NCT02869282) | Institut Bergonié | 2011-06-01 |
| Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer (NCT01326312) | GTx | 2011-06-01 |
| Stereotactic Body Radiotherapy for Prostate Cancer (NCT01352598) | Mercy Research | 2011-06-01 |
| Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer (NCT01313559) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-06-01 |
| Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate Cancer (NCT03526510) | Dr. Patrick Cheung | 2011-06-01 |
| Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a (NCT02381015) | Endeavor Health | 2011-06-01 |
| Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer (NCT01335204) | Medical University of South Carolina | 2011-06-01 |
| Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients (NCT01313273) | Ipsen | 2011-06-01 |
| Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint (NCT01394042) | Radiological Associates of Sacramento Medical Group Inc. | 2011-06-01 |
| Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate (NCT01508390) | Boston Medical Center | 2011-06-01 |
| Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer (NCT01478308) | New Mexico Cancer Research Alliance | 2011-06-01 |
| A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer (NCT01685190) | Institute of Cancer Research, United Kingdom | 2011-06-01 |
| Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001 (NCT01429064) | Orion Corporation, Orion Pharma | 2011-06-01 |
| Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery (NCT02024178) | NYU Langone Health | 2011-06-01 |
| Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer (NCT01341652) | University of Wisconsin, Madison | 2011-05-23 |
| A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy (NCT01302041) | Astellas Pharma Inc | 2011-05-06 |
| Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer (NCT01308567) | Sanofi | 2011-05-05 |
| IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen (NCT01314118) | Janssen Biotech, Inc. | 2011-05-04 |
| Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer (NCT01354951) | Memorial Sloan Kettering Cancer Center | 2011-05-01 |
| A Comparison of Totally Intravenous and Inhalation Anesthesia for Intraocular Pressure During Robot-Assisted Laparoscopic Radical Prostatectomy (NCT01744262) | Yonsei University | 2011-05-01 |
| Prostate Cancer Survivors Moving Toward Exercise (PROMOTE) Trial (NCT01410656) | University of Alberta | 2011-05-01 |
| Early Rehabilitation of Cancer Patients (NCT01588262) | Haukeland University Hospital | 2011-05-01 |
| Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. (NCT01353625) | Celgene | 2011-04-25 |
| A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck (NCT01059643) | Eli Lilly and Company | 2011-04-01 |
| Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide (NCT01344564) | Urology of Virginia | 2011-04-01 |
| PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma (NCT01304485) | Phoenix Molecular Imaging | 2011-04-01 |